Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Acquired perforating dermatosis associated with natalizumab.
Passive induction of experimental allergic encephalomyelitis.
Cognitive rehabilitation in Multiple sclerosis.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Altered inter-subregion connectivity of the default mode network in relapsing remitting multiple sclerosis: a functional and structural connectivity study.
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
Uses of complementary and alternative medicine in multiple sclerosis.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Mitochondrial changes within axons in multiple sclerosis: an update.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Pages
« first
‹ previous
…
210
211
212
213
214
215
216
217
218
…
next ›
last »